Dedicated to my students, past, present and future, and to all students of economics, worldwide, to assist in their pursuit of economics knowledge.
Search This Blog
Tuesday, February 16, 2010
Positive Externalities of Consumption
Although some scientists (and self-labeled "experts") question the effectiveness and risk of inoculations (i.e. shots), many people argue that providing vaccinations against various diseases like H1N1 and the mumps prevents such illness from occurring. If I pay to get a shot for H1N1 because I do not want this flu, then I also will not pass this flu to those around me. However, those around me did not have to pay for my inoculation even though they reap the benefits. Therefore, the marginal social benefit of inoculations is greater than the marginal private benefit which does not include society's benefit from less infectious people (MSB > MPB). This is an example of a positive externality of consumption.
The free market for inoculations sees equilibrium at quantity Q1 (and price P1) which is below the socially efficient level of output Q*. Between Q1 and Q*, MSB > MSC and a potential welfare gain is possible (yellow triangles).
What can the government do to intervene in this market failure to achieve this potential welfare gain? First, they could subsidize the consumption of such forms of health care to make the consumption of such goods/services cheaper. In the graph, this is shown by the orange MSC + subsidy curve which reduces the price of inoculations (to P2) and increases quantity to the socially efficient level Q*. However, when governments spend money on subsidies, there is always the argument that this money could have been spent elsewhere (opportunity cost).
Another option would be to spend taxpayer money for a positive ad campaign that would encourage the community to get inoculated against various diseases like H1N1. The aim of this campaign would be to increase consumers' private benefit / utility for consuming vaccinations because they would feel better about protecting themselves against disease. Graphically, this is shown by the orange arrow indicating a rightward shift of MPB towards MSB (and thus Q*). Of course, the opportunity cost argument would apply here as well and often some members of the community are very critical of vaccinations.
Other possible government interventions include forcing the public to get inoculated which might violate civil rights.
Subscribe to:
Post Comments (Atom)
This comment has been removed by the author.
ReplyDeleteI came across your blog because I was searching up the diagrams for externalities on google images. I'm writing my econ notes at the moment, getting ready for IB mocks and I just wanted to say this blog is awesomeee! So thanks for the help ^^.
ReplyDeleteHey! I am glad to stop by your site and know more about P-f curve . Keep it up! This is a good read. I will be looking forward to visit your page again and for your other posts as well. Thank you for sharing your thoughts about p-f curve in your area.
ReplyDeleteAn overall reliability strategy must be grounded in a fundamental understanding of how equipment fails. RCM Blitz™ is the hub of GPAllied’s integrated approach to designing and implementing a failure modes driven reliability strategy, returning results in a fraction of the time of traditional RCM methods. integrated approach to designing and implementing a failure modes driven reliability strategy, returning results in a fraction of the time.
Hi there! glad to drop by your page and found these very interesting and informative stuff. Thanks for sharing, keep it up!
ReplyDelete- p-f curve or P-F interval seems like a simple concept, but it is often misunderstood. The P-F Curve is often misunderstood because users take for granted that point "P" (the potential failure) has already been clearly defined.